In addition to modulating risk for AD, the A152T tau mutation also influences risk for dementia with Lewy bodies (DLB) [17] and the spectrum of frontotemporal dementia disorders, including PSP and CBD [9]. The gene discussed is MAPT; the disease is Lewy body dementia.